Interferon α2b and Fotemustine in Patients with Disseminated Melanoma

U. R. Kleeberg,Ch. Gawlik,E.-B. Bröcker,Ch. Boewer,R.P. Chatelain,W. Queißer,M. Westerhausen,B. Rothe,G. Friedrich,Lutz Edler

Interferon α2b and Fotemustine in Patients with Disseminated Melanoma

1995

U. R. Kleeberg
Ch. Gawlik
E.-B. Bröcker
Ch. Boewer
R.P. Chatelain
W. Queißer
M. Westerhausen
B. Rothe
G. Friedrich
Lutz Edler

Background: The introduction of r-Interferon alpha (rlfn α) into cytostatic chemotherapy of metastatic melanoma appears to improve objective remission rates. Favorable results of ea

Keywords:

Melanoma
Fotemustine
Immunology
Tumor progression
Interferon
Cancer research
Medicine
Chemotherapy
Oncology
in patient
palliative treatment
metastatic melanoma
interferon α2b
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations